Search

everythinglearnresearchcommunity

for

Search:↓

FDA-approved low-level light/laser therapy devices can significantly increase hair density in people with pattern hair loss.

Taking biotin supplements can be risky and often lacks evidence of effectiveness for skin, hair, and nail issues.

Certain drugs are effective for skin conditions like psoriasis, vitiligo, and hair loss.

At-home laser and light skin devices are less effective than professional ones, with limited scientific evaluation, but some show promise for wrinkles, hair growth, and acne.

New genetic insights have improved understanding of hair loss, leading to a new test and treatments, but more research is needed on the test and laser comb effectiveness.

Mesotherapy might help reduce fat in specific areas for those close to their ideal weight, but more research and care are needed to ensure safety.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

Platelet-rich plasma treatment for non-scarring hair loss shows mixed results and needs more research.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Low-dose oral minoxidil may help treat hair loss but is not FDA-approved and can cause side effects like unwanted hair growth and heart issues.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

Some drugs can cause serious side effects like heart issues and nervous system problems, but certain drugs for Parkinson's and overactive bladder may be safer, though they still have some common side effects.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Exosomes from platelet-rich plasma may help heal wounds but need more research for hair growth and skin use.

JAK inhibitors show promise for treating various skin diseases.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

EGFR-TKIs can cause significant skin, nail, and organ side effects.

Injection lipolysis effectively reduces small fat deposits and should be done with care and proper patient selection.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

St. John's Wort extract and oil safety in cosmetics is unclear; more data needed on photosensitization, toxicity, and human irritation.

PDRN helps repair tissue and improve wound healing with a high safety profile.

The document concluded that FDA-approved treatments like minoxidil and finasteride are effective for hair loss, while the effectiveness of natural remedies and other non-approved treatments is not well-supported by evidence.

Minoxidil, finasteride, and low-level laser light therapy are effective FDA-approved treatments for hair loss.

Platelet-Rich Plasma (PRP) treatment can potentially increase hair density and quality in people with hair loss, but more research is needed to confirm its effectiveness.

Use of cosmeceuticals during pregnancy and breastfeeding is not recommended due to insufficient safety data.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Tofacitinib helped regrow hair in most patients with severe hair loss.

The document concludes that various treatments for skin conditions are effective, but some require further research, and certain factors like gender and lifestyle can influence disease outcomes.